top of page


Schizophrenia is a complex, chronic mental health disorder characterized by a range of symptoms that disrupt a person’s thinking, feeling, behavior, and perception of reality. This severe condition affects about 1% of the population and typically manifests in late adolescence or early adulthood. Its exact cause remains unknown, but a combination of genetic, brain chemistry, and environmental factors is believed to contribute to its development. Schizophrenia is marked by episodes of psychosis, featuring hallucinations, delusions, and thought disorder, alongside negative symptoms such as diminished emotional expression and social withdrawal.


The hallmark symptoms of schizophrenia are divided into three main categories: positive, negative, and cognitive. Positive symptoms refer to the addition of abnormal thoughts or behaviors, including hallucinations (hearing or seeing things that aren’t there), delusions (false beliefs not based in reality), and thought disorders (unusual or dysfunctional ways of thinking). Negative symptoms are characterized by a reduction or loss of ability to function normally. For example, a person may show less facial expression, have difficulty starting and sustaining activities, or speak in a dull, disconnected way. Cognitive symptoms involve problems with attention, memory, and executive functions, making it hard for the person to organize their thoughts, make decisions, or understand information quickly.


Diagnosis of schizophrenia involves a comprehensive clinical assessment, including a psychiatric evaluation and, sometimes, neuroimaging or other medical tests to rule out other conditions. There is no definitive test for schizophrenia; diagnosis is based on the patient’s self-reported experiences and observed behaviors. A diagnosis typically requires that symptoms have been present for six months, including at least one month of active positive symptoms.


Despite its challenges, schizophrenia's prognosis has improved over the years, thanks to advances in treatment and a better understanding of the disorder. Early diagnosis and treatment significantly affect the long-term outlook, with many individuals experiencing improvement in symptoms and functioning over time. However, people with schizophrenia often face challenges related to stigma, discrimination, and misunderstanding about the disorder, which can hinder their ability to seek help and integrate into society.


Ongoing research into the causes and treatment of schizophrenia offers hope for future advancements in managing the disorder. Studies exploring the genetics of schizophrenia, novel antipsychotic medications with fewer side effects, and more effective psychosocial interventions are underway. The goal is to improve the quality of life for those affected by schizophrenia and to eventually find a cure.


Treatment for schizophrenia usually involves a combination of antipsychotic medications and psychosocial therapies. Antipsychotic drugs can be very effective in managing the positive symptoms of schizophrenia, but they do not eliminate the disorder and are less effective against negative and cognitive symptoms. Psychosocial interventions, such as cognitive-behavioral therapy (CBT), assertive community treatment, and supportive therapy, aim to improve social functioning and manage the impact of negative and cognitive symptoms. Rehabilitation, including job counseling, social skills training, and supported employment, can also be crucial in helping individuals with schizophrenia live independently. Modern forms of CBT that have been specifically tailored to support people with schizophrenia can be very effective to improve all the symptoms of schizophrenia and is recommended in national and international guidelines for the effective treatment of schizophrenia.

bottom of page